PKM2 in carcinogenesis and oncotherapy.

about

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression.

P2860

Q52716585-ECA11188-167E-4010-9A1E-BD56A3A3AD17 Q54980243-4AC62D9C-A6DE-43F6-A997-A0F704928D13

P2860

PKM2 in carcinogenesis and oncotherapy.

Item

http://www.wikidata.org/entity/Q47153446

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PKM2 in carcinogenesis and oncotherapy.

@en

PKM2 in carcinogenesis and oncotherapy.

@nl

type

Item

label

PKM2 in carcinogenesis and oncotherapy.

@en

PKM2 in carcinogenesis and oncotherapy.

@nl

prefLabel

PKM2 in carcinogenesis and oncotherapy.

@en

PKM2 in carcinogenesis and oncotherapy.

@nl

P1476

PKM2 in carcinogenesis and oncotherapy.

@en

P2093

Hailian Wang

http://www.w3.org/2001/XMLSchema#string

Rongsheng Tong

http://www.w3.org/2001/XMLSchema#string

Suya Du

http://www.w3.org/2001/XMLSchema#string

Tiantian Lei

http://www.w3.org/2001/XMLSchema#string

Xia He

http://www.w3.org/2001/XMLSchema#string

Xiang Li

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

Yilong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of small molecule inhibitors of pyruvate kinase M2

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription

Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase

The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells

Understanding the Warburg effect: the metabolic requirements of cell proliferation

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis

Pyruvate kinase M2 is a phosphotyrosine-binding protein

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

P304

110656-110670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22529

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29299177

http://www.w3.org/2001/XMLSchema#string

P932

5746412

http://www.w3.org/2001/XMLSchema#string

PKM2 in carcinogenesis and oncotherapy.

about

P2860

P2860

PKM2 in carcinogenesis and oncotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932